[et_pb_section fb_built=“1″ _builder_version=“4.25.0″ _module_preset=“default“ global_colors_info=“{}“ theme_builder_area=“post_content“][et_pb_row _builder_version=“4.25.0″ _module_preset=“default“ global_colors_info=“{}“ theme_builder_area=“post_content“][et_pb_column type=“4_4″ _builder_version=“4.25.0″ _module_preset=“default“ global_colors_info=“{}“ theme_builder_area=“post_content“][et_pb_text _builder_version=“4.25.0″ _module_preset=“default“ hover_enabled=“0″ global_colors_info=“{}“ theme_builder_area=“post_content“ sticky_enabled=“0″]<\/p>\n
biosafety4u.berlin GmbH and Z.A.S. Zentral Archiv Service GmbH create joint cooperation in cell biobanking<\/strong><\/p>\n Berlin, Neubrandenburg, 19 May 2023<\/p>\n biosafety4u.berlin GmbH, a service provider for genetic engineering facilities in Germany, and Z.A.S. Zentral Archiv Service GmbH, a Rhenus company specialized in archiving and biobanking in compliance to GLP and GMP regulations, announce today the creation of a joint cooperation to establish a holistic service offer for external cell biobanking in a regulatory context.<\/p>\n Z.A.S cell biobanking capabilities can help clients to maintain a long-term storage of valuable production cell lines for a variety of applications:<\/p>\n \u201eThis partnership will enable our clients to benefit from a broader service portfolio \u201c, says Christian Lange, Quality Manager GLP and GCLP @ biosafety4u.berlin GmbH. He has also been approved by the local competent authority as external Biosafety Officer for Z.A.S. Zentral Archiv Service according to \u00a729 GenTSV (German Act for Genetic Engineering). <\/p>\n Dr. Benjamin Bader, Managing Director @ Z.A.S. Zentral Archiv Service GmbH, adds: \u201eRegulated biobanking can be troublesome due to continuously changing and increasing demands on safety aspects. Together with biosafety4u.berlin we provide a full spectrum biobanking service to our clients now including safety assessments and consultation\u201d. <\/p>\n <\/p>\n\n